SEC 13F Intelligence

Managers / Q4 2019 · view latest →

P2 Capital Partners, LLC

CIK 0001406313 · 590 MADISON AVENUE, 25TH FLOOR, NEW YORK, NY, 10022 · (212) 508-5500

Reported Value
$1.4B
Q4 2019
Positions
16
Filings on Record
30
2019–present window
Filed
Feb 14, 2020
original filing

Summary

P2 Capital Partners, LLC reported $1.4B in U.S.-listed holdings across 16 positions for Q4 2019.

Its largest position, NXST, represents 14.6% of the portfolio.

Compared with Q3 2019, the fund opened 0 new positions and exited 1.

Portfolio Metrics

Turnover
+5.8%
vs prior filed quarter
Top-10 Concentration
+84.5%
share of reported value
Largest Position
+14.6%
Nexstar Media

Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.

Reported Value by Quarter

13F Reported Value
Q4 ’18: $991MQ4 ’18Q1 ’19: $1.2BQ2 ’19: $1.3BQ3 ’19: $1.5BQ4 ’19: $1.4BQ4 ’19Q1 ’20: $836MQ2 ’20: $1.2BQ3 ’20: $1.3BQ4 ’20: $1.5BQ4 ’20Q1 ’21: $1.5BQ2 ’21: $1.3BQ3 ’21: $1.2BQ4 ’21: $1.3BQ4 ’21Q1 ’22: $1.1BQ2 ’22: $883MQ3 ’22: $810MQ4 ’22: $756MQ4 ’22Q1 ’23: $780MQ2 ’23: $859MQ3 ’23: $764MQ4 ’23: $909MQ4 ’23Q1 ’24: $846MQ2 ’24: $912MQ3 ’24: $876MQ4 ’24: $589MQ4 ’24Q1 ’25: $515MQ2 ’25: $522MQ3 ’25: $520MQ4 ’25: $390MQ4 ’25Q1 ’26: $210Mfilingsflow.com

Portfolio Composition

By security type
Common Stock: 97.7%Other: 2.3%
  • Common Stock · 97.7% · $1.3B
  • Other · 2.3% · $31M

Quarter-over-Quarter Changes full breakdown →

vs Q3 2019 (amended baseline)

IssuerMoveShare ΔShares nowValue ΔValue now
QUOTUSDQUOTIENT TECHNOLOGY INCSOLD OUT1.42M0$11M$0
HEALTH INS INNOVATIONS INCADDED+800.0K1.63M+$11M$31M
MDMEDNAX INCADDED+1.15M3.90M+$46M$108M
TSAACI WORLDWIDE INCTRIMMED692.6K1.26M$13M$48M
MMSMAXIMUS INCTRIMMED388.9K860.1K$33M$64M
BCOBRINKS COTRIMMED711.1K1.64M$46M$149M
BCBCADCOTT CORP QUETRIMMED1.85M4.52M$18M$62M
EBIXEUREBIX INCTRIMMED395.1K1.05M$26M$35M

Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.

Holdings — Q4 2019

15 positions
#IssuerClass% PortfolioValueShares
1NXSTNEXSTAR MEDIA GROUP INChistory →CL A14.63%$199M1.70M
2ACHCACADIA HEALTHCARE COMPANY INhistory →COM13.58%$185M5.58M
3HGVHILTON GRAND VACATIONS INChistory →COM11.35%$155M4.50M
4BCOBRINKS COhistory →COM10.94%$149M1.64M
5MDMEDNAX INChistory →COM7.95%$108M3.90M
6AQUAUSDEVOQUA WATER TECHNOLOGIES COhistory →COM6.04%$82M4.34M
7CBZCBIZ INChistory →COM5.51%$75M2.79M
8FULFULLER H B COhistory →COM5.31%$72M1.40M
9MMSMAXIMUS INChistory →COM4.69%$64M860.1K
10BCBCADCOTT CORP QUEhistory →COM4.53%$62M4.52M
11SP PLUS CORPCOM3.83%$52M1.23M
12TSAACI WORLDWIDE INChistory →COM3.51%$48M1.26M
13GRPNCHFGROUPON INChistory →COM3.26%$44M18.57M
14EBIXEUREBIX INChistory →COM NEW2.57%$35M1.05M
15HEALTH INS INNOVATIONS INCCOM CL A1.17%$16M830.0K

Filing History

QuarterReported ValuePositionsFiledTypeLinks
Q1 2026$210M10May 15, 202613F-HRchanges · EDGAR ↗
Q4 2025$390M10Feb 17, 202613F-HRchanges · EDGAR ↗
Q3 2025$520M13Nov 14, 202513F-HRchanges · EDGAR ↗
Q2 2025$522M13Aug 14, 202513F-HRchanges · EDGAR ↗
Q1 2025$515M12May 15, 202513F-HRchanges · EDGAR ↗
Q4 2024$589M11Feb 14, 202513F-HRchanges · EDGAR ↗
Q3 2024$876M15Nov 14, 202413F-HRchanges · EDGAR ↗
Q2 2024$912M18Aug 14, 202413F-HRchanges · EDGAR ↗
Q1 2024$846M15May 15, 202413F-HRchanges · EDGAR ↗
Q4 2023$909M15Feb 14, 202413F-HRchanges · EDGAR ↗
Q3 2023$764M14Nov 14, 202313F-HRchanges · EDGAR ↗
Q2 2023$859M15Aug 14, 202313F-HRchanges · EDGAR ↗
Q1 2023$780M15May 15, 202313F-HRchanges · EDGAR ↗
Q4 2022$756M15Feb 23, 202313F-HRchanges · EDGAR ↗
Q3 2022$810M19Nov 14, 202213F-HRchanges · EDGAR ↗
Q2 2022$883M21Aug 15, 202213F-HRchanges · EDGAR ↗
Q1 2022$1.1B22May 16, 202213F-HRchanges · EDGAR ↗
Q4 2021$1.3B21Feb 14, 202213F-HRchanges · EDGAR ↗
Q3 2021$1.2B20Nov 15, 202113F-HRchanges · EDGAR ↗
Q2 2021$1.3B19Aug 16, 202113F-HRchanges · EDGAR ↗
Q1 2021$1.5B20May 17, 202113F-HRchanges · EDGAR ↗
Q4 2020$1.5B18Feb 16, 202113F-HRchanges · EDGAR ↗
Q3 2020$1.3B18Nov 16, 202013F-HRchanges · EDGAR ↗
Q2 2020$1.2B17Aug 14, 202013F-HRchanges · EDGAR ↗
Q1 2020$836M14May 15, 202013F-HRchanges · EDGAR ↗
Q4 2019$1.4B16Feb 14, 202013F-HRchanges · EDGAR ↗
Q3 2019$1.5B16Nov 14, 201913F-HRchanges · EDGAR ↗
Q2 2019$1.3B16Aug 14, 201913F-HRchanges · EDGAR ↗
Q1 2019$1.2B17May 15, 201913F-HRchanges · EDGAR ↗
Q4 2018$991M17Feb 14, 201913F-HRchanges · EDGAR ↗

13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.